Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances

OBJECTIVES: Alteplase is commonly recommended for acute ischaemic stroke within 4.5 hours after stroke onset. The Third European Cooperative Acute Stroke Study (ECASS III) is the only trial reporting statistically significant efficacy for clinical outcomes for alteplase use 3–4.5 hours after stroke...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Evid Based Med
Autori principali: Alper, Brian Scott, Foster, Gary, Thabane, Lehana, Rae-Grant, Alex, Malone-Moses, Meghan, Manheimer, Eric
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548536/
https://ncbi.nlm.nih.gov/pubmed/32430395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjebm-2020-111386
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi